Senolytic treatment alleviates doxorubicin‐induced chemobrain is a research paper published in Aging Cell (2024). On theSindex it has a DataRank of 0.505. It has been cited 28 times.
Scored on demand from live citation data
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
Base Score Contribution
0.505
From this paper's citation signal
Citation Network Contribution
0
Citation network not refreshed for this result
This paper's DataRank is currently driven only by its base citation score. Citation network data was not refreshed for this result.
Learn more about DataRank methodology →National Institutes of Health
Grant: 5R01AG052258-04
Systemic inflammation in regulating the onset and progression of brain aging
National Institutes of Health
Grant: 5P30AG028740-07
RESOURCE CORE 3: BIOSTATISTICS AND DATA MANAGEMENT CORE
National Institutes of Health
Grant: 1R21AG068205-01
Age-associated impaired executive function: Rescue by NMDA receptor upregulation
National Institutes of Health
Grant: 5R01AG037984-13
Estrogen and cognition over the lifespan
National Institutes of Health
Grant: 5R01AG063801-03
Develop BCL-xL proteolysis targeting chimeras as safer and better senolytics
Fields of Study
Keywords